Viking Therapeutics Insider Trades
NASDAQ: VKTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 1 · $149.91K
- Sales
- 20 · $22.25M
- Shares bought / sold
- 4.47K / 664.04K
- Net activity
- Net selling $22.1 million
Viking Therapeutics insider activity
Over the last 12 months, Viking Therapeutics insiders reported 43 transactions on SEC Form 4: 1 open-market purchase and 20 sales. Insiders bought $149,913 and sold $22.3 million worth of stock, for net insider selling of $22.1 million. The largest seller was Lian Brian, with $14.0 million in reported sales.
The most recent filing shows Kelly-Gemmell Dorothy Elizabeth (Director) reporting a transaction in 6,333 shares on Aug 1, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put VKTX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
VKTX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 1, 2026 | Kelly-Gemmell Dorothy ElizabethDirector | Award | 6,333 | — | Form 4 |
| Jul 29, 2026 | Mancini MariannaChief Operating Officer | Sale | 18,217 | $609.64K | Form 4 |
| Jul 29, 2026 | ZANTE GREGChief Financial Officer | Sale | 21,217 | $710.14K | Form 4 |
| Jul 29, 2026 | Lian BrianPresident & CEO | Sale | 148,517 | $4.95M | Form 4 |
| Jul 28, 2026 | Mancini MariannaChief Operating Officer | Award | 31,667 | — | Form 4 |
| Jul 28, 2026 | ZANTE GREGChief Financial Officer | Award | 31,667 | — | Form 4 |
| Jul 28, 2026 | Lian BrianPresident & CEO | Award | 221,667 | — | Form 4 |
| Mar 10, 2026 | Aubuchon Neil WilliamChief Commercial Officer | Buy | 4,475 | $149.91K | Form 4 |
| Jan 5, 2026 | ZANTE GREGChief Financial Officer | Sale | 1,500 | $48.13K | Form 4 |
| Jan 5, 2026 | ZANTE GREGChief Financial Officer | Sale | 10,300 | $352.63K | Form 4 |
| Jan 5, 2026 | ZANTE GREGChief Financial Officer | Sale | 13,900 | $464.02K | Form 4 |
| Jan 5, 2026 | ZANTE GREGChief Financial Officer | Sale | 31,961 | $1.03M | Form 4 |
| Jan 5, 2026 | Lian BrianPresident & CEO | Sale | 6,400 | $224.42K | Form 4 |
| Jan 5, 2026 | Lian BrianPresident & CEO | Sale | 41,276 | $1.41M | Form 4 |
| Jan 5, 2026 | Lian BrianPresident & CEO | Sale | 53,279 | $1.78M | Form 4 |
| Jan 5, 2026 | Lian BrianPresident & CEO | Sale | 132,454 | $4.28M | Form 4 |
| Jan 5, 2026 | Mancini MariannaChief Operating Officer | Sale | 1,600 | $56.12K | Form 4 |
| Jan 5, 2026 | Mancini MariannaChief Operating Officer | Sale | 10,500 | $359.30K | Form 4 |
| Jan 5, 2026 | Mancini MariannaChief Operating Officer | Sale | 13,600 | $453.88K | Form 4 |
| Jan 5, 2026 | Mancini MariannaChief Operating Officer | Sale | 31,961 | $1.03M | Form 4 |
| Jan 2, 2026 | FOEHR MATTHEW WDirector | Award | 3,150 | — | Form 4 |
| Jan 2, 2026 | FOEHR MATTHEW WDirector | Sale | 16,000 | $561.69K | Form 4 |
| Jan 2, 2026 | FOEHR MATTHEW WDirector | Option exercise | 16,000 | $53.28K | Form 4 |
| Jan 2, 2026 | Rowland Charles A JrDirector | Award | 3,150 | — | Form 4 |
| Jan 2, 2026 | ZANTE GREGChief Financial Officer | Award | 32,049 | — | Form 4 |
| Jan 2, 2026 | ZANTE GREGChief Financial Officer | Award | 41,000 | — | Form 4 |
| Jan 2, 2026 | Rouan Sarah KathrynDirector | Award | 3,150 | — | Form 4 |
| Jan 2, 2026 | SINGLETON J MATTHEWDirector | Award | 3,150 | — | Form 4 |
| Jan 2, 2026 | Lian BrianPresident & CEO | Award | 224,080 | — | Form 4 |
| Jan 2, 2026 | Lian BrianPresident & CEO | Award | 78,400 | — | Form 4 |
| Jan 2, 2026 | MACARTNEY LAWSONDirector | Award | 3,150 | — | Form 4 |
| Jan 2, 2026 | Mancini MariannaChief Operating Officer | Award | 32,049 | — | Form 4 |
| Jan 2, 2026 | Mancini MariannaChief Operating Officer | Award | 41,000 | — | Form 4 |
| Oct 28, 2025 | ZANTE GREGChief Financial Officer | Sale | 6,185 | $216.48K | Form 4 |
| Oct 28, 2025 | Mancini MariannaChief Operating Officer | Sale | 6,185 | $216.49K | Form 4 |
| Oct 28, 2025 | Lian BrianPresident & CEO | Sale | 38,989 | $1.36M | Form 4 |
| Oct 27, 2025 | ZANTE GREGChief Financial Officer | Award | 11,117 | — | Form 4 |
| Oct 27, 2025 | Rowland Charles A JrDirector | Sale | 60,000 | $2.13M | Form 4 |
| Oct 27, 2025 | Rowland Charles A JrDirector | Award | 22,000 | $107.36K | Form 4 |
| Oct 27, 2025 | Rowland Charles A JrDirector | Award | 22,000 | $127.60K | Form 4 |
| Oct 27, 2025 | Rowland Charles A JrDirector | Award | 16,000 | $71.68K | Form 4 |
| Oct 27, 2025 | Mancini MariannaChief Operating Officer | Award | 11,117 | — | Form 4 |
| Oct 27, 2025 | Lian BrianPresident & CEO | Award | 70,084 | — | Form 4 |
| Jul 3, 2025 | Mancini MariannaChief Operating Officer | Sale | 4,266 | $118.47K | Form 4 |
| Jul 3, 2025 | Lian BrianPresident & CEO | Sale | 26,889 | $747.63K | Form 4 |
| Jul 3, 2025 | ZANTE GREGChief Financial Officer | Sale | 4,266 | $118.43K | Form 4 |
| Jul 2, 2025 | Mancini MariannaChief Operating Officer | Award | 7,667 | — | Form 4 |
| Jul 2, 2025 | Lian BrianPresident & CEO | Award | 48,333 | — | Form 4 |
| Jul 2, 2025 | ZANTE GREGChief Financial Officer | Award | 7,667 | — | Form 4 |
| Apr 11, 2025 | FOEHR MATTHEW WDirector | Option exercise | 20,786 | $166.29K | Form 4 |
| Mar 31, 2025 | Rouan Sarah KathrynDirector | Buy | 1,240 | $29.94K | Form 4 |
| Mar 31, 2025 | Rouan Sarah KathrynDirector | Buy | 1,240 | $29.94K | Form 4 |
| Jan 6, 2025 | Lian BrianPresident & CEO | Sale | 19,000 | $823.02K | Form 4 |
| Jan 6, 2025 | Lian BrianPresident & CEO | Sale | 175,490 | $7.49M | Form 4 |
| Jan 6, 2025 | ZANTE GREGChief Financial Officer | Sale | 4,700 | $203.60K | Form 4 |
| Jan 6, 2025 | ZANTE GREGChief Financial Officer | Sale | 45,609 | $1.95M | Form 4 |
| Jan 6, 2025 | Mancini MariannaChief Operating Officer | Sale | 5,100 | $220.91K | Form 4 |
| Jan 6, 2025 | Mancini MariannaChief Operating Officer | Sale | 49,115 | $2.10M | Form 4 |
| Jan 3, 2025 | Lian BrianPresident & CEO | Award | 163,333 | — | Form 4 |
| Jan 3, 2025 | Lian BrianPresident & CEO | Award | 92,800 | — | Form 4 |
| Jan 3, 2025 | ZANTE GREGChief Financial Officer | Award | 21,667 | — | Form 4 |
| Jan 3, 2025 | ZANTE GREGChief Financial Officer | Award | 44,533 | — | Form 4 |
| Jan 3, 2025 | Mancini MariannaChief Operating Officer | Award | 21,667 | — | Form 4 |
| Jan 3, 2025 | Mancini MariannaChief Operating Officer | Award | 44,533 | — | Form 4 |
| Nov 8, 2024 | MACARTNEY LAWSONDirector | Sale | 2,000 | $137.33K | Form 4 |
| Nov 8, 2024 | MACARTNEY LAWSONDirector | Option exercise | 2,000 | $11.60K | Form 4 |
| Oct 28, 2024 | ZANTE GREGChief Financial Officer | Sale | 1,206 | $98.22K | Form 4 |
| Oct 28, 2024 | ZANTE GREGChief Financial Officer | Sale | 7,967 | $642.54K | Form 4 |
| Oct 28, 2024 | ZANTE GREGChief Financial Officer | Sale | 6,050 | $482.66K | Form 4 |
| Oct 28, 2024 | ZANTE GREGChief Financial Officer | Sale | 15,825 | $1.25M | Form 4 |
| Oct 28, 2024 | ZANTE GREGChief Financial Officer | Sale | 23,082 | $1.79M | Form 4 |
| Oct 28, 2024 | ZANTE GREGChief Financial Officer | Sale | 9,265 | $712.80K | Form 4 |
| Oct 28, 2024 | ZANTE GREGChief Financial Officer | Sale | 18,620 | $1.41M | Form 4 |
| Oct 28, 2024 | ZANTE GREGChief Financial Officer | Sale | 49,672 | $3.70M | Form 4 |
| Oct 28, 2024 | ZANTE GREGChief Financial Officer | Option exercise | 51,000 | $434.52K | Form 4 |
| Oct 28, 2024 | ZANTE GREGChief Financial Officer | Option exercise | 26,000 | $150.80K | Form 4 |
| Oct 28, 2024 | ZANTE GREGChief Financial Officer | Option exercise | 4,251 | $19.89K | Form 4 |
| Oct 28, 2024 | ZANTE GREGChief Financial Officer | Option exercise | 12,750 | $99.07K | Form 4 |
| Oct 25, 2024 | SINGLETON J MATTHEWDirector | Sale | 16,000 | $1.27M | Form 4 |
| Oct 25, 2024 | SINGLETON J MATTHEWDirector | Option exercise | 16,000 | $71.68K | Form 4 |
| Oct 25, 2024 | Rouan Sarah KathrynDirector | Sale | 11,000 | $889.79K | Form 4 |
| Oct 25, 2024 | Rouan Sarah KathrynDirector | Option exercise | 11,000 | $53.68K | Form 4 |
| Sep 20, 2024 | Lian BrianPresident & CEO | Sale | 200 | $14.40K | Form 4 |
| Sep 20, 2024 | Lian BrianPresident & CEO | Sale | 119,874 | $8.53M | Form 4 |
| Sep 20, 2024 | Lian BrianPresident & CEO | Sale | 96,056 | $6.77M | Form 4 |
| Sep 20, 2024 | Lian BrianPresident & CEO | Option exercise | 166,130 | $1.29M | Form 4 |
| Sep 20, 2024 | SINGLETON J MATTHEWDirector | Sale | 10,300 | $715.85K | Form 4 |
| Sep 20, 2024 | SINGLETON J MATTHEWDirector | Option exercise | 10,300 | $12.26K | Form 4 |
| Aug 21, 2024 | Lian BrianPresident & CEO | Sale | 1,000 | $69.90K | Form 4 |
| Aug 21, 2024 | Lian BrianPresident & CEO | Option exercise | 1,000 | $7.77K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4